• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[增殖细胞核抗原(PCNA)在原发性胆囊癌中的表达及其意义]

[The expressions of proliferating cell nuclear antigen (PCNA) in primary gallbladder carcinoma and its significance].

作者信息

Qing D, Xia L, Zhang X

机构信息

Affiliated Hospital of Guiyang Medical College.

出版信息

Zhonghua Wai Ke Za Zhi. 1995 Feb;33(2):102-4.

PMID:7656696
Abstract

Anti-PCNA monoclonal antibody and ABC staining were used to study the expressions of proliferating cell nuclear antigen/cyclin in patients with primary gallbladder carcinoma (31 cases), adenoma and tumor-like lesions of gallbladder (10 cases), and chronic cholecystitis (7 cases). The PCNA indices were 373.48 +/- 219.83, 94.9 +/- 93, and 56 +/- 28.63, respectively. This index was significantly higher in malignant lesions than in benign diseases (P < 0.01). There was a tendency that the higher the PCNA index, the lower differential degree of the gallbladder carcinoma (P < 0.01). But there were no significant correlations between the PCNA indices and the pathohistological types, the nevin classifications and the TNM classifications of the gallbladder carcinoma (P > 0.05).

摘要

采用抗增殖细胞核抗原(PCNA)单克隆抗体及ABC染色法,对31例原发性胆囊癌、10例胆囊腺瘤及肿瘤样病变和7例慢性胆囊炎患者进行增殖细胞核抗原/细胞周期蛋白表达的研究。PCNA指数分别为373.48±219.83、94.9±93和56±28.63。该指数在恶性病变中显著高于良性疾病(P<0.01)。有PCNA指数越高,胆囊癌分化程度越低的趋势(P<0.01)。但PCNA指数与胆囊癌的病理组织学类型、Nevin分期及TNM分期之间无显著相关性(P>0.05)。

相似文献

1
[The expressions of proliferating cell nuclear antigen (PCNA) in primary gallbladder carcinoma and its significance].[增殖细胞核抗原(PCNA)在原发性胆囊癌中的表达及其意义]
Zhonghua Wai Ke Za Zhi. 1995 Feb;33(2):102-4.
2
[The expression and significance of proliferating cell nuclear antigen/cyclin in cholangiocarcinoma and gallbladder carcinoma].
Zhonghua Wai Ke Za Zhi. 1995 Jul;33(7):437-8.
3
A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.一种新的细胞增殖标志物:与结直肠癌患者增殖细胞核抗原相比的胞质胸苷激酶
Anticancer Res. 2000 Nov-Dec;20(6C):4815-20.
4
Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.肝外胆管原位癌和浸润癌中增殖细胞核抗原及Ki-67抗原免疫反应性的细胞增殖差异及其预后意义
Cancer. 1996 Nov 1;78(9):1881-7. doi: 10.1002/(sici)1097-0142(19961101)78:9<1881::aid-cncr6>3.0.co;2-i.
5
Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.萎缩性口腔扁平苔藓及咀嚼槟榔患者中p53和增殖细胞核抗原(PCNA)的高表达。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Apr;99(4):471-8. doi: 10.1016/j.tripleo.2004.10.018.
6
Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA.Vater乳头腺瘤中的腺瘤及微小癌——p53和增殖细胞核抗原
Hepatogastroenterology. 1999 May-Jun;46(27):1959-62.
7
Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder, and its relationship to prognosis.
Scand J Clin Lab Invest. 1995 Aug;55(5):377-82. doi: 10.3109/00365519509104976.
8
Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.自发性犬肺癌中的增殖指数:增殖细胞核抗原(PCNA)、Ki-67(MIB1)及有丝分裂计数
J Comp Pathol. 1999 May;120(4):321-32. doi: 10.1053/jcpa.1998.0281.
9
Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.Fas与Fas配体在胆囊癌免疫逃逸中的作用及机制
World J Gastroenterol. 2005 Jun 28;11(24):3719-23. doi: 10.3748/wjg.v11.i24.3719.
10
Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).壶腹癌:倍体、细胞周期分析及增殖细胞核抗原(PCNA)的预后意义
Hepatogastroenterology. 1999 Mar-Apr;46(26):1187-91.